{"ticker": {"uuid": "338b774a-ce5a-4a0e-ab42-73406c553ac7", "symbol": "LABB", "name": "Genomma Lab Internacional, S.A.B. de C.V.", "exchange": "MEX", "country": "MX", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Genomma Lab Internacional S.A.B. de C.V. Second Quarter 2026 Earnings Results Conference Call", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQT2ZpOHBVVGt0cEtpYkVTbWJhWlZiMUtjNXVRRmZFbFRUa0FJZFpwTjk3M1VPMTRyalBQMjN5Z1NiSXphNlpKclBWVWdoN1dFbVI3WTJOUGpXWl81NnFzYm5fdFdqVW1weE9BZ016UkxwSklxY2RqSXZUV2JNblZocDZ5MmpSUkhyRWM1ekpXOGhLRWIy?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Only Four Days Left To Cash In On Genomma Lab Internacional. de's (BMV:LABB) Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxQVzJ3bC15TnREQU9DNjFTS0hOTXpFLXdobFlVWHljbWl4S3lSMzYtQjdQVEV2bHJJNnlrTDJYTmRFWEpfcklRZXYzSXVsLW1YSjVPeDRFN3hhTE5qNFNGem5WUjZJTk1HZ2ZXanJQcWd1ZklDbzNydjJIbUZSUUdDd2EydHZLcU5FZjEyNTZrRHUtRHlVSEJ1ZGtGYUdvR1dOZXdtU0FabHdlMXE3T1lkaDViV2NKY0dOXzhmZVhsUG5vaFpkZHhiQy00OHhhbllaSFBCWFhPYndPM1FFV0hMX0FhbU1ZaWQxTTZ5T2dxNlNydVAxdUlRcHF30gH_AUFVX3lxTE5veWdwQy1FNFp3cVZQcDY5TVFieGRUUVZzMHN1SnJlM0dsV0k1enRuWldKejR4amVWamxrWjJwVjRacjJMSjRqV3JwM2FoTzczdm5CZ0d3ZGE2Rnp2d3hPTFdZZ0ZvWmRPbzBLZDJ5STExUHZTdFViTnNpWEZJS3JzRDJBLTNUV0c0Q2N5TEhDUmtHSnBzYWJIaG5GQjlnVEl0eEhuYlBNS3dSUkZYT1JmNTRLVFJzUE9aLV9CUzVTamJkWmhyOTRNRzczMkRPbUM2NDJMR0VOVHdjdGNjMnFwZnhXejdZNDdpMVp6R2hZWE9HTEl1YmY5LWlUbFNrdw?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oramed Subsidiary Oravax Medical and Genomma Lab Internacional Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business Development in Latin America", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "PR Newswire", "published_at": "2021-11-18T08:00:00+00:00", "published_display": "18 Nov 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPdmhHdUZSTHFKX1RhV1ZtZXp6UTk0X1VnRU95Y1diMzJfUXEyeTVXSGxUYkg0dl8yVmJYMWRGM0Y5Y01DXzFUcUNjaTNVZ3ZlemhCenRMUlpxaFo5Zm9YTDBzUG9waXRhaDFQRl9IeU40bHFfTWxLczQwMExLaDdwQVJiV0J5cFJ1RTFVVWVR?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-18T15:37:24+00:00", "published_display": "18 Aug 2020 15:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Genomma Lab Internacional S.A.B. de C.V. Second Quarter 2026 Earnings Results Conference Call", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQT2ZpOHBVVGt0cEtpYkVTbWJhWlZiMUtjNXVRRmZFbFRUa0FJZFpwTjk3M1VPMTRyalBQMjN5Z1NiSXphNlpKclBWVWdoN1dFbVI3WTJOUGpXWl81NnFzYm5fdFdqVW1weE9BZ016UkxwSklxY2RqSXZUV2JNblZocDZ5MmpSUkhyRWM1ekpXOGhLRWIy?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Only Four Days Left To Cash In On Genomma Lab Internacional. de's (BMV:LABB) Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxQVzJ3bC15TnREQU9DNjFTS0hOTXpFLXdobFlVWHljbWl4S3lSMzYtQjdQVEV2bHJJNnlrTDJYTmRFWEpfcklRZXYzSXVsLW1YSjVPeDRFN3hhTE5qNFNGem5WUjZJTk1HZ2ZXanJQcWd1ZklDbzNydjJIbUZSUUdDd2EydHZLcU5FZjEyNTZrRHUtRHlVSEJ1ZGtGYUdvR1dOZXdtU0FabHdlMXE3T1lkaDViV2NKY0dOXzhmZVhsUG5vaFpkZHhiQy00OHhhbllaSFBCWFhPYndPM1FFV0hMX0FhbU1ZaWQxTTZ5T2dxNlNydVAxdUlRcHF30gH_AUFVX3lxTE5veWdwQy1FNFp3cVZQcDY5TVFieGRUUVZzMHN1SnJlM0dsV0k1enRuWldKejR4amVWamxrWjJwVjRacjJMSjRqV3JwM2FoTzczdm5CZ0d3ZGE2Rnp2d3hPTFdZZ0ZvWmRPbzBLZDJ5STExUHZTdFViTnNpWEZJS3JzRDJBLTNUV0c0Q2N5TEhDUmtHSnBzYWJIaG5GQjlnVEl0eEhuYlBNS3dSUkZYT1JmNTRLVFJzUE9aLV9CUzVTamJkWmhyOTRNRzczMkRPbUM2NDJMR0VOVHdjdGNjMnFwZnhXejdZNDdpMVp6R2hZWE9HTEl1YmY5LWlUbFNrdw?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oramed Subsidiary Oravax Medical and Genomma Lab Internacional Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business Development in Latin America", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "PR Newswire", "published_at": "2021-11-18T08:00:00+00:00", "published_display": "18 Nov 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPdmhHdUZSTHFKX1RhV1ZtZXp6UTk0X1VnRU95Y1diMzJfUXEyeTVXSGxUYkg0dl8yVmJYMWRGM0Y5Y01DXzFUcUNjaTNVZ3ZlemhCenRMUlpxaFo5Zm9YTDBzUG9waXRhaDFQRl9IeU40bHFfTWxLczQwMExLaDdwQVJiV0J5cFJ1RTFVVWVR?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-18T15:37:24+00:00", "published_display": "18 Aug 2020 15:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 4, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 4, "score": 50, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 62, "events": [{"event": "general", "label": "Market update", "weight": 1.1, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 14.73, "latest_week": "2026-07-17", "one_week_move": -3.1, "four_week_move": -0.3, "twelve_week_move": -11.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.582481, "market_dynamics_buy_signal": false, "relative_strength": -19.021229, "fair_value_gap": -17.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 56.3603, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.1% over one week, -0.3% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 52, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "PR Newswire", "count": 1}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 2}, {"label": "Earnings", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "62/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.1% over one week, -0.3% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Genomma Lab Internacional S.A.B. de C.V. Second Quarter 2026 Earnings Results Conference Call"}], "updated_at": "2026-07-21T19:35:44.997903+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}